Evaluation of Exercise Application Technology in Adolescents

NCT ID: NCT05720377

Last Updated: 2023-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-01

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to evaluate the use of an exercise phone application and a continuous glucose monitor and their impact on metabolic disease in adolescents with obesity, prediabetes and Type 2 diabetes. Participants will be asked to wear a continuous glucose monitor (Freestyle Libre) and if they are in the intervention group also participate in using an exercise phone application as well as have scheduled interval contact with a health professional in between scheduled clinic visits to assess how they are reaching their goals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be recruited directly from the Childrens of Alabama pediatric endocrine clinic. Thirty patients who have obesity, prediabetes or Type 2 diabetes will be enrolled. During the enrollment phase, flyers will be posted in clinic and emails will be distributed to potential participants. Our study team will approach interested participants during their routine clinic visit. Consent will be obtained by study team during their endocrine clinic visit. Review of their medical records will be done and age, gender and race will be extracted from the medical record. A baseline visit with vital signs, blood work, a physical exam and nutritional counseling will be completed. Once enrolled, the patients will then be randomized.Within this pilot trial, we will randomize 15 adolescents/teenagers who either have obesity, prediabetes or Type 2 diabetes, to access to an exercise regimen and 15 adolescents to control intervention using a permuted block randomization scheme. The randomization scheme will contain 6 blocks of size 5 allowing for 30 randomized in the group with obesity, prediabetes and Type 2 diabetes.

Those who are in the intervention group will then be given access to frequent telephone counseling to follow-up their nutrition and exercise goals, access to exercise application and accelerometer as described below. Follow-up will then be completed at 3 and 6 months with a physical exam, vital signs, blood draw.

Intervention Group

Access provided to exercise application Provided with Fitbit to wear and measure activity Weekly check-in with provider to determine how exercise goals have been that week. If unable to reach, we will text securely a clinic check-in and provide a healthy tip of the week.

Meeting with nutrition at Baseline visit

Continuous glucose monitor provided (plan to wear for 14 days during each month)

Non-Intervention Group

Meeting with nutrition at Baseline visit

Continuous glucose monitor provided (plan to wear for 14 days at baseline visit, 3 month visit and 6 month visit)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes PreDiabetes Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

longitudinal
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obese, receives access to exercise phone application

obese, receives access to exercise phone application and interval contact by health provider in between clinic visits , receives continuous glucose monitor

Group Type EXPERIMENTAL

continuous glucose monitor (Freestyle Libre

Intervention Type DEVICE

15 minute phone interview by health care provider to assess health goals set at clinic visits.

Obese, no intervention

obese, receives continuous glucose monitor

Group Type NO_INTERVENTION

No interventions assigned to this group

Prediabetes, receives access to exercise phone application

prediabetes receives access to exercise phone application and interval contact by health provider in between clinic visit, receives continuous glucose monitor

Group Type EXPERIMENTAL

continuous glucose monitor (Freestyle Libre

Intervention Type DEVICE

15 minute phone interview by health care provider to assess health goals set at clinic visits.

Prediabetes, no intervention

prediabetes, receives continuous glucose monitor

Group Type NO_INTERVENTION

No interventions assigned to this group

Type 2 diabetes, receives access to exercise phone application

prediabetes receives access to exercise phone application and interval contact by health provider in between clinic visit, receives continuous glucose monitor

Group Type EXPERIMENTAL

continuous glucose monitor (Freestyle Libre

Intervention Type DEVICE

15 minute phone interview by health care provider to assess health goals set at clinic visits.

Type 2 diabetes, no intervention

Type 2 diabetes, receives continuous glucose monitor

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

continuous glucose monitor (Freestyle Libre

15 minute phone interview by health care provider to assess health goals set at clinic visits.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Contact by health care provider

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI \> 95th percentile
* A1c\> 6.5%
* Age 14-17 (2 years post-menarchal)

Inclusion for Prediabetes Arm

* Age 14-17 (2 years post-menarchal)
* A1c 5.7-6.4%

Inclusion for Obesity Arm

* Age 14-17 (2 years post-menarchal)
* A1c 5.7-6.4%

Exclusion Criteria

* BMI \<95th percentile
* Specific obesity syndrome
* Inability to participate in exercise workouts
Minimum Eligible Age

14 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christy Foster

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-300007608

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Enduring Exercise Habits
NCT03634423 COMPLETED NA